"Northern Light Mercy Cancer Care understands that cancer is personal. That’s why patients are at the core of our individualized approach, with a clinical team that is responsive and accountable to your preferences, needs, and values, ensuring that patients and families are at the center of everything we do. Mercy’s comprehensive program gives you the attention you expect, with high quality, personalized, and coordinated care. Patients have access to clinical trials and full spectrum medical, psychosocial, and supportive care close to home."

During the past decade, Mercy Oncology / Hematology Center; Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Oncology / Hematology Center; Oncology" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Oncology / Hematology Center; Oncology" are "Breast Cancer" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Mercy Oncology / Hematology Center; Oncology" in a lesser frequency.

Most popular intervention types in "Mercy Oncology / Hematology Center; Oncology" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials), "Obinutuzumab" (1 trials), "Prednisone" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Oncology / Hematology Center; Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mercy Oncology / Hematology Center; Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mercy Oncology / Hematology Center; Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Oncology / Hematology Center; Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".